Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
An ongoing phase II clinical trial is evaluating the effects of different doses of bimagrumab (up to 30 mg/kg) in combination with semaglutide for the treatment of obesity
266 WuG.ShiY.HanL.FengC.GeY.YuY.et al (2020)
Examples included: Paroxysmal Nocturnal Haemoglobinuria (PNH) Immune Thrombocytopenia (ITP) Hemophagocytic Lymphohistiocytosis (HLH) Myelofibrosis Haemophilia von Willebrand disease, and other inherited bleeding disorders These studies examined treatment patterns, clinical outcomes, disease burden, healthcare utilization, and patient experiences outside controlled clinical trial environments
10.1371/journal.pone.0203657 PLoS One
Complete regular lab work to monitor IGF-1, hormone levels, and metabolic markers, adjusting protocols as needed
US$ 22.50
US$ 25.37
US$ 21.95
US$ 23.11
US$ 25.02
US$ 25.16
US$ 28.90
US$ 24.78